Kyntra Bio (KYNB) Restructuring Costs (2023 - 2026)

Kyntra Bio has disclosed Restructuring Costs across 4 years of filings, most recently posting $11000.0 for Q2 2026.

• In Q2 2026, Restructuring Costs fell 97.2% year-over-year to $11000.0; the TTM figure through Jun 2026 stood at $67000.0 (down 99.67% YoY), while the FY2025 annual figure was $553000.0, down 97.16% from the prior year.
• Restructuring Costs came in at $11000.0 for Q2 2026 at Kyntra Bio, down from $22000.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $18.6 million in Q3 2024 to a low of -$7000.0 in Q4 2025.
• Average Restructuring Costs over 4 years is $3.6 million, with a median of $126000.0 recorded in 2025.
• Year-over-year, Restructuring Costs soared 47.18% in 2024 and sank 100.74% in 2025.
• Over 4 years, Restructuring Costs stood at $12.6 million in 2023, then sank by 92.5% to $946000.0 in 2024, then slumped by 100.74% to -$7000.0 in 2025, then jumped by 257.14% to $11000.0 in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were $11000.0 in Q2 2026, $22000.0 in Q1 2026, and -$7000.0 in Q4 2025.